We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

January 9, 2020

News You Need - 3 Big Little Things from HealthXL - January 2020

Commentary
Chandana Fitzgerald
&

This is your first monthly digest of 2020! We have reviewed the three most noteworthy news stories in digital health from the last few weeks and explained their relevance below. We’ve analysed what they mean for the industry, and why you should know about them. Reach out to me if you wish to connect with our friends from the industry who can quite literally ‘get behind the headlines’.

Over 250 digital health investments in 2019.

Story Snapshot: InsureTech and Telemed capture the lionshare of the Top 20 2019 digital health investments followed by Digital Therapeutics and Virtual Pharmacies

 

Why it's Notable?

 The top 20 highest value investments indicated 4 key themes:  

  1. InsureTech - Two of the top three 500M+ rounds went to this category - Bright Health ($635), Clover Health ($500M)
  2. Telemed Consultation Services - Babylon Health ($550M) and Tencent Trusted Doctor ($250M) won two behemoth investment rounds this year
  3. DTx and Behavioural Health continues to attract investment - Quartet ($60M), Pear ($64M), Ro ($85M), Omada ($73M), Calm ($88M)
  4. Virtual Pharmacies saw some large rounds, including Capsule ($200M) and Hims ($100M)

 

Industry Implications:

  1. Payers are recognising the need to work with their other health counterparts in innovating and making their practices and services more accessible, transparent.  
  2. Telemed investments highlight increased access to care across geographies but also drawing skepticism in terms of the necessity of rounds of this size ($200M+) for these types of services. 
  3. 2 of the top 20 investment spots go to virtual pharmacy showing that investments in the virtual pharmacy space haven’t been deterred by the roadblocks faced by Pillpack to date, and further address access barriers. The combination of telemedicine and e-pharmacy can be powerful for the consumer. 
  4. Global is the way to go. All of the investments in 2019 have shown a global spread and reach, thus showing that digital health is not only the focus of the West but also (and more obviously) "mobile-first" societies. 


Robert Garber
Robert Garber
Partner
7Wire Ventures

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

One Medical - the first digital health IPO of 2020.

Story Snapshot: The tech-enabled primary care provider One Medical, which combines brick-and-mortar doctor visits with around the clock virtual care, is the first digital health company to file for IPO in 2020. 


Why is it notable?

With Livongo, Health Catalyst, Peloton, Phreesia, Progyny and Change Healthcare all going public last year, many heralded 2019 as the year of digital health IPOs. One Medical’s recent filing seems to indicate a likely continuation of the IPO chasing trend within the industry. 


Industry implications:

  1. One Medical’s IPO filing is a likely testament to the popularity and growth of hybrid care offerings, resulting from the accessibility as well as convenience they offer to their members.
  2. While its new IPO status will certainly increase One Medical’s brand visibility, this is no protection against customer churn in favour of more traditional health care providers.
  3. Learnings from cautionary IPO tales - amplified investor hype is only partly to blame; companies must ensure that their houses are in order, otherwise the IPO process can quickly turn into an expensive misfiring!
Carlos Rodarte
Carlos Rodarte
SVP, Life Science Strategy & Business Development
Health Catalyst

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Voluntis, DTx company, partners with Salesforce. Yep, you heard that right.

Story snapshot: Salesforce is a leader in CRM and has just partnered with Voluntis, to implement Voluntis Practice Solutions (VPS), its full-service platform supporting DTx prescription and reimbursement. Salesforce’s Health Cloud, Community Cloud, Sales Cloud and Einstein Analytics solutions will be deployed together to power VPS.


Why it is notable?
Salesforce is a force to reckon with and has widespread adoption across health systems already.

  1. DTx companies are really going hard in pursuing adoption of their solutions among clinical institutions because there has been a lag in patient and clinician uptake of the same over the years. This is another example of the same.
  2. The platform will also integrate the most recent CPT codes established by Centers for Medicare & Medicaid Services (CMS).


Industry Implications:  

  1. While it is not too clear to me how Salesforce's platforms work with clinical decision trees, Q2 2020 will tell us how and when this pilot kicks off. If the promise is real, the scale of access and adoption could be unprecedented.
  2. Backend tasks, billing, revenue management, etc may be the first to be impacted by this partnership, which is exciting enough because that is where the first opportunity for automation lies.
  3. If this partnership does scale, other DTx may follow suit to allow for widespread prescribing of digital assets in the management of disease.
Jessica Shull
Jessica Shull
European Lead
Digital Therapeutics Alliance

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

What are the best routes to market in DTx?

12th April @ 11:00am EDT

Join us as we discuss what are the most scalable and sustainable routes to market in DTx. Great opportunity to connect with peers and meet new people.

Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Robert Stern
Robert Stern
Founder & CEO, At Point Of Care
Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Robert Stern
Robert Stern
Founder & CEO, At Point Of Care
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Masterclass - The regulation of DTx

15th April @ 10:30am EDT

Join us in this Masterclass led by Stephen Gibney from BlueBridge Technologies as we discuss the regulation of DTx. Great opportunity to Listen, engage and most importantly, enjoy.

Featuring
Stephen Gibney
Stephen Gibney
Quality Assurance Manager at BlueBridge Technologies
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Featuring
Stephen Gibney
Stephen Gibney
Quality Assurance Manager at BlueBridge Technologies
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Why is Medtech right for DTx and vice versa

22nd April @ 11:30am EDT

Join our Digital Health Meeting as we discuss why Medtech is right for DTx and vice versa. Apply promptly to get involved in the conversation, network with peers and share your thoughts on the topic.

Featuring
Lisa Suennen
Lisa Suennen
Group Leader, Manatt Ventures
Vivian Emmely de Ruijter
Vivian Emmely de Ruijter
Senior Manager, Digital and Technology Group, Manatt Ventures at Manatt, Phelps & Phillips, LLP
Featuring
Lisa Suennen
Lisa Suennen
Group Leader, Manatt Ventures
Vivian Emmely de Ruijter
Vivian Emmely de Ruijter
Senior Manager, Digital and Technology Group, Manatt Ventures at Manatt, Phelps & Phillips, LLP
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

DTx - Overview of market and deals

28th April @ 10:30AM EDT

Join our Digital Health Meeting focused on the overview of market and deals in the DTx industry. Apply promptly to secure your place in the discussion and network with peers.

Featuring
Ethan Wergelis-Isaacson
Ethan Wergelis-Isaacson
Digital Health Strategy & Business Development , Otsuka Pharmaceutical Companies
Featuring
Ethan Wergelis-Isaacson
Ethan Wergelis-Isaacson
Digital Health Strategy & Business Development , Otsuka Pharmaceutical Companies

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

What are the best routes to market in DTx?

12th April @ 11:00am EDT

Join us as we discuss what are the most scalable and sustainable routes to market in DTx. Great opportunity to connect with peers and meet new people.

Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Robert Stern
Robert Stern
Founder & CEO, At Point Of Care
Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Robert Stern
Robert Stern
Founder & CEO, At Point Of Care
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support

The future of digital medical education

13th April @ 10:30am EDT

Join us as we discuss the future of digital medical education and its impact on digital health adoption. Great opportunity to connect with peers, engage in thought-provoking conversations and meet new people.

Featuring
Joshua Landy MD
Joshua Landy MD
Chief Medical Officer, Figure 1
Meg Barron
Meg Barron
Vice President, Digital Health Strategy, American Medical Association
Featuring
Joshua Landy MD
Joshua Landy MD
Chief Medical Officer, Figure 1
Meg Barron
Meg Barron
Vice President, Digital Health Strategy, American Medical Association
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support

Role of digital patient communities in 2021

14th April @ 10:30am EDT

Join our Digital Health Meeting as we discuss the role of digital patient communities in 2021. Apply now to secure your place in the conversation and gain valuable insights from thought leaders in the industry.

Featuring
Chelsea Pan
Chelsea Pan
Partnership Engagement Manager, Verily Life Sciences
Carlos Rodarte
Carlos Rodarte
Founder & Managing Director, Volar Health LLC
Featuring
Chelsea Pan
Chelsea Pan
Partnership Engagement Manager, Verily Life Sciences
Carlos Rodarte
Carlos Rodarte
Founder & Managing Director, Volar Health LLC
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Masterclass - The regulation of DTx

15th April @ 10:30am EDT

Join us in this Masterclass led by Stephen Gibney from BlueBridge Technologies as we discuss the regulation of DTx. Great opportunity to Listen, engage and most importantly, enjoy.

Featuring
Stephen Gibney
Stephen Gibney
Quality Assurance Manager at BlueBridge Technologies
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Featuring
Stephen Gibney
Stephen Gibney
Quality Assurance Manager at BlueBridge Technologies
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.